Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The German-Israeli Foundation for Scientific Research and Development | OTHER |
| Prof. Simone Shamay-Tsoory, University of Haifa | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the clinical potential of oxytocin (OT) as an adjunct to a cognitive-behavioral group-based shortterm intervention for participants suffering from loneliness.
Loneliness has a high prevalence in Western societies and poses a significant health problem. Among its many implications, loneliness has been associated with increased risk for coronary heart disease and stroke, depression, cognitive decline, dementia, and mortality. At the neural level, several networks may be involved in loneliness, including the reward circuitry, which mediates social reward, and the amygdala, which signals social threat. Intranasal OT has been reported to regulate activity in both the reward system and the amygdala. Therefore, it may serve as an adjunct to a cognitive-behavioral short-term intervention for high lonely participants.
In this randomized, double-blind, placebo-controlled design study, effects of intranasal OT (24 international units (UI)) as a pharmacological augmentation given before the start of four sessions of a cognitive-behavioral short-term intervention in groups of six to eight participants (based on established interpersonal psychotherapy modules to reduce loneliness) will be investigated. Healthy, but high lonely participants will complete functional magnetic resonance imaging (fMRI) tasks in a separate testing session before the start of the intervention (testing session 1). In the first session of the intervention, the psychotherapist will inform the participants about the procedure of the intervention and participants will get to know the other participants in their intervention group (testing session 2). In the next four sessions (testing sessions 3-6), participants will receive 24 IU of intranasal OT 30 minutes before the start of the intervention. Sessions of the intervention will be conducted weekly. After completion of the intervention, participants will again undergo fMRI scanning (testing session 7). Three weeks and three months after completion of the intervention, follow-up measurements of the experienced loneliness and subjective well-being will be collected.
All fMRI testing sessions (1 and 7) will include following tasks:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Oxytocin (24 IU) | Experimental | Intranasal administration of 24 international units (IU) of oxytocin (OT) 30 minutes before the start of four intervention sessions |
|
| Placebo | Placebo Comparator | Intranasal administration of a placebo spray 30 minutes before the start of four intervention sessions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxytocin nasal spray | Drug | Intranasal administration of 24 international units oxytocin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Scores on the UCLA Loneliness Scale | Loneliness, as measured via the University of California, Los Angeles (UCLA) loneliness scale before the start (testing session 1) and after completion of the intervention (testing session 7) (+ follow-up measurements 3 weeks and 3 months after completion of the intervention), will be analyzed using mixed ANOVAs with the software SPSS and Bonferroni-corrected post-hoc t-tests. | Five to seven weeks (+ Follow-Up measurements 3 weeks and 3 months after completion of the intervention) |
| State loneliness (numeric rating scale) | State loneliness will be measured on a numeric rating scale ranging from 1 to 100 at the start and the end of each testing session and analyzed using mixed ANOVAs in SPSS and Bonferroni-corrected post-hoc t-tests. | Five to seven weeks (+ Follow-Up measurements 3 weeks and 3 months after completion of the intervention) |
| Scores on the World Health Organization (WHO) Five Well-Being Index | Psychological well-being will be assessed using the World Health Organization (WHO) Five Well-Being Index before each testing session and analyzed using mixed ANOVAs in SPSS and Bonferroni-corrected post-hoc t-tests. | Five to seven weeks (+ Follow-Up measurements 3 weeks and 3 months after completion of the intervention) |
| Scores on the Perceived Stress Scale | Perceived stress will be assessed using the Perceived Stress Scale (PSS-10) before each testing session and analyzed using mixed ANOVAs in SPSS and Bonferroni-corrected post-hoc t-tests. | Five to seven weeks (+ Follow-Up measurements 3 weeks and 3 months after completion of the intervention) |
| Neural responses in the trust game | The BOLD signal as response to the trust game will be compared to the risk game and changes in the signal from testing session 1 to 7 will be compared between the OT and PLC groups. Results from both fMRI testing sessions will be compared to a non-lonely healthy control group (data were collected in a previous study with the same fMRI tasks in two fMRI sessions five to seven weeks apart from each other). Analyses will focus on anatomically defined regions of interests (ROIs) associated with trust (insula, amygdala, nucleus accumbens, and ventromedial prefrontal cortex). For analyses of fMRI data, standard procedures of the software SPM12 will be used. The family-wise error rate will be used to correct p-values for multiple comparisons and p < .05 will be considered significant. fMRI data will be correlated with behavioral data of the trust game and the UCLA Loneliness scores. |
| Measure | Description | Time Frame |
|---|---|---|
| Interpersonal distance | Interpersonal distance will be assessed by an adapted version of an established stop-distance paradigm. Participants start from a distance of ~ 2 m and move towards the investigator until their ideal distance is reached (trials 1 and 3) or until they feel slightly uncomfortable (trials 2 and 4). The task will be applied by the same investigator at testing sessions 1 and 7. Data will be analyzed using mixed ANOVAs and Bonferroni-corrected t-tests in SPSS to compare treatment group as well as lonely participants and non-lonely controls. |
| Measure | Description | Time Frame |
|---|---|---|
| Oxytocin plasma concentrations | Oxytocin plasma concentrations will be assessed in testing sessions 1 and 7 before the fMRI scans will be conducted. | Five to seven weeks (before the start and after the completion of the intervention) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rene Hurlemann, MSc, MD, PhD | University of Oldenburg | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Psychiatry, University of Bonn | Bonn | 53105 | Germany |
Not provided
| Label | URL |
|---|---|
| Neuromodulation of Emotion (NEMO) research group | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Participants will receive either 24 IU of intranasal OT or placebo (PLC) over the four intervention sessions. All participants in one intervention group will receive the same substance.
Not provided
Not provided
Not provided
| Placebo | Drug | The placebo nasal sprays contains identical ingredients except for the peptide itself. |
|
| Five to seven weeks (fMRI task will be completed before the start and after the completion of the intervention and will take about 15 minutes) |
| Amount of invested money in the trust game as an economic value of trust | Behavioral data of the trust game (invested money) will be analyzed using mixed ANOVAs in SPSS and compared between the OT and PLC groups. Post-hoc t-tests will be Bonferroni-corrected. Behavioral data will be correlated with fMRI data of the trust game and the UCLA Loneliness scores. | Five to seven weeks (fMRI task will be completed before the start and after the completion of the intervention and will take about 15 minutes) |
| Neural responses to interpersonal touch | BOLD signals of slow touch trials will be contrasted with fast touch trials. Again, results of the OT group will be compared with the PLC group and results of lonely participants will be compared to the results of a non-lonely healthy control group. Analyses will focus on ROIs associated with the processing of social touch (amygdala, hippocampus, insula, and primary somatosensory cortex). For analyses of fMRI data, standard procedures of SPM12 will be used (preprocessing & a two-stage approach based on the general linear model for statistical analyses). The family-wise error rate will be used to correct p-values for multiple comparisons and p < .05 will be considered significant. Post-hoc t-tests will be Bonferroni-corrected. fMRI data will be correlated with behavioral data of the touch task and the UCLA loneliness scores. | Five to seven weeks (fMRI task will be completed before the start and after the completion of the intervention and will take about 15 minutes) |
| Comfort ratings of interpersonal touch in the fMRI task (visual analogue scale) | Behavioral data of the fMRI interpersonal touch task (comfort ratings on a visual analogue scale) will be analyzed using mixed ANOVAs in SPSS and compared between the OT and the PLC group. Post-hoc t-tests will be Bonferroni-corrected. Comfort ratings will be correlated with fMRI data of the interpersonal touch task and the UCLA loneliness scores. | Five to seven weeks (fMRI task will be completed before the start and after the completion of the intervention and will take about 15 minutes) |
| Therapeutic relationship (positive bonding) measured by the Group Questionnaire (GQ-D) | The therapeutic relationship (positive bonding) will be measured after all intervention sessions using the Group Questionnaire (GQ-D; subscale Positive Bonding). OT effects will be analyzed by conducting mixed ANOVAs and Bonferroni-corrected post-hoc t-tests in SPSS. | Five weeks |
| Therapeutic relationship (positive working) measured by the Group Questionnaire (GQ-D) | The therapeutic relationship (positive working) will be measured after all intervention sessions using the GQ-D (subscale Positive Working). OT effects will be analyzed by conducting mixed ANOVAs and Bonferroni-corrected post-hoc t-tests in SPSS. | Five weeks |
| Therapeutic relationship (negative relationship) measured by the Group Questionnaire (GQ-D) | The therapeutic relationship (negative relationship) will be measured after all intervention sessions using the GQ-D (subscale Negative Relationship). OT effects will be analyzed by conducting mixed ANOVAs and Bonferroni-corrected post-hoc t-tests in SPSS. | Five weeks |
| Five to seven weeks (before the start and after the completion of the intervention) |
| Neural activity at resting state | fMRI will be performed to measure BOLD-signal while participants lay in the MRI-scanner with eyes open. Participants will be instructed to look at a fixation cross for ~ 6 minutes. Functional connectivity will be analyzed using default preprocessing parameters implemented in the CONN-toolbox. Changes in functional connectivity will be contrasted between treatment groups and activity will be compared to those of non-lonely controls. | Five to seven weeks (fMRI task will be completed before start and after completion of the intervention and will take about 6 minutes) |